Table 3: Antimicrobial susceptibility of the isolated organisms of necrotizing fasciitis patients.
Organism |
Patients number |
Antimicrobial |
Susceptibility rate |
Staphylococcus aureus |
259 |
Ampicillin-Sulbactam |
100% |
Clindamycin |
100% |
||
Vancomycin |
100% |
||
Pseudomonas aeruginosa
|
216
|
Piperacillin-tazobactam |
100% |
Amikacin |
100% |
||
|
|
Imipenem |
100% |
Staphylococcus Epidermidis |
194 |
Ceftazidime |
100% |
Tazobactam |
98% |
||
Enterococcus species |
172 |
Amikacin |
100% |
Ceftriaxone |
94% |
||
Klebsiella pneumoniae |
136 |
Cefuroxim |
97% |
Imipenem-cilastatin |
95% |
||
Bacteroides |
113 |
Clindamycin |
100% |
Vancomycin |
100% |
||
Proteus mirabilis |
107 |
Cefoxitin |
90% |
Acinetobacter |
82 |
Imipenem |
95% |
Citrobacter species |
64 |
Imipenem |
90% |
Alcaligenes faecalis |
47 |
Trimethoprim-sulfamethoxazole |
85% |
Beta-hemolytic streptococcus |
56 |
Trimethoprim-sulfamethoxazole |
90% |
Bacitracin |
90% |
||
Escherichia coli |
41 |
Piperacillin-tazobactam |
100% |
Cefuroxime |
100% |
||
Ampicillin |
100% |
||
Clostridium difficile |
23 |
Metronidazole |
100% |
Vancomycin |
100% |